Prelude Therapeutics Incorporated

PRLDNASDAQ Global Select·USD·Closed

PRLDNASDAQ·USD·Closed

$4.60

−8.91%

$4.60

−$0.45 (8.91%)

52W Range

78thpctl

Volume

0.62×avg

Mkt Cap

261.89MUSD

P/E

-4.3TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

78thpctl

Volume

0.62×avg

Market Cap

261.89MUSD

P/E Ratio

-4.3TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin-503.2%

ROIC-104.3%

Financially safe

Stretched

Debt / equity0.29×

Interest coverage0.0×

Current ratio2.03×